Sign up to save your podcasts
Or
Share 313: Biotech layoffs, founder-focused VC, & a big pharma exit
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
313: Biotech layoffs, founder-focused VC, & a big pharma exit
STAT's West Coast biotech reporter Jonathan Wosen joins "The Readout LOUD" to discuss what’s driving workforce cuts. Plus, entrepreneurs Alexis Borisy and Zach Weinberg call in to discuss their biotech incubator Curie.Bio and how they hope to “free the founders.” We also discuss a big change in Pfizer’s leadership and the debate over a new side effect tied to the diabetes drug Ozempic.
View all episodes
By STAT
4.5
304304 ratings
STAT's West Coast biotech reporter Jonathan Wosen joins "The Readout LOUD" to discuss what’s driving workforce cuts. Plus, entrepreneurs Alexis Borisy and Zach Weinberg call in to discuss their biotech incubator Curie.Bio and how they hope to “free the founders.” We also discuss a big change in Pfizer’s leadership and the debate over a new side effect tied to the diabetes drug Ozempic.
More shows like The Readout Loud
View all
Planet Money
30,845 Listeners
a16z Podcast
1,040 Listeners
Odd Lots
1,795 Listeners
KFF Health News' 'What the Health?'
478 Listeners
The Long Run with Luke Timmerman
122 Listeners
Talks at GS
84 Listeners
The Journal.
5,950 Listeners
Tradeoffs
391 Listeners
Biotech 2050 Podcast
59 Listeners
BioCentury This Week
29 Listeners
Hard Fork
5,462 Listeners
Raising Health
147 Listeners
Biotech Hangout
18 Listeners
Ground Truths
51 Listeners
Money Stuff: The Podcast
371 Listeners